Oligo Factory was featured in a Chemical and Engineering News story on the tremendous growth of the oligonucleotide industry. Several quotes featuring Oligo Factory are below.
Oligo Factory, which launched in 2006 to serve customers with projects in early-stage development, recently opened a 1,200 m2 manufacturing facility in Holliston, Massachusetts. Around the same time, the company received an undisclosed amount of investment from firms including Research Corporation Technologies and BroadOak Capital Partners.
CEO Chris Boggess says Oligo Factory emphasizes cost-effective supply and tailoring oligonucleotides to novel applications. “Since the inception of the company, we have built our own instrumentation and our own software and used our own engineering expertise,” he says.
Boggess sees a lot of room for innovation. “I got three calls yesterday—a preclinical therapeutics company, a diagnostics company, and a life science tools company,” he said recently. “All three want oligonucleotides that have never been made in the history of oligo synthesis. And we can say, ‘This is what you can expect from us.’ ”exceeding supply. Unreliable synthesis timelines are also causing delays in bringing life-saving medicines to clinical trials and the public. While we may not be a household name yet, we’ve been in this business for over fifteen years and are ready to show everyone that there’s a better way to get custom oligos made at scale. We’re committed to growing our business and ensuring that we meet the needs of our clients in a timely manner while maintaining the highest standards of purity and quality.”
